Article
The class XIV myosin of Toxoplasma gondii, TgMyoA, is druggable in an animal model of…
medRxiv · 2023 · Anne Kelsen, author Robyn S Kent, author Anne K Snyder, author Eddie Wehri, author Stephen J Bishop, author Rachel V Stadler, author Cameron Powell, author Pramod K Rompikuntal, author Martin J Boulanger, author David M Warshaw, author Nicholas J Westwood, author Julia Schaletzky, author Gary E Ward, author
Key facts
| Title | The class XIV myosin of Toxoplasma gondii, TgMyoA, is druggable in an animal model of infection |
|---|---|
| First author | Anne Kelsen, author Robyn S Kent, author Anne K Snyder, author Eddie Wehri, author Stephen J Bishop, author Rachel V Stadler, author Cameron Powell, author Pramod K Rompikuntal, author Martin J Boulanger, author David M Warshaw, author Nicholas J Westwood, author Julia Schaletzky, author Gary E Ward, author |
| Journal | medRxiv |
| Published | Feb 13, 2023 |
| DOI | 10.1101/2022.09.09.507210 |
| Devices mentioned | K800781 |
| Product codes mentioned | KIP, KIT, NDS, KIS, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1